To The Moon

As per my Thursday post, US market did not rally and close on a high (click here ! for details, Repost to share !). The media said US stocks closed mixed on Thursday, booking weekly losses on the final session of the week. Most media “agreed” that the 2 factors that most affected market sentiments, particularly blue-chip Dow Jones Industrial Average were: Trump’s latest bitch-fit over what Fed chair Jerome Powell had said in his xx speech about overall US economy. Historic drop in $UnitedHealth(UNH)$ after the insurer reported its quarterly earnings and delivered an outlook that disappointed Wall Street.

$SPDR S&P Biotech ETF ( $Spdr S&P Biotech Etf(XBI)$ )$ $Pfizer ( $Pfizer(PFE)$ )$ $S&P 500(. $S&P 500(.SPX)$ )$ $Dow Jones Industrial Average(. $Dow Jones(.DJI)$ )$As of April 18, 2025, the U.S. stock market is reeling from a volatile week, with the S&P 500 shedding 2.8% on April 17 and the Dow Jones Industrial Average dropping 1,200 points in a single session. Fears of escalating trade tensions and a hawkish Federal Reserve have sparked widespread selling. Yet, amid the chaos, biotech stocks are staging an unexpected rally, driven by breakthrough drug approvals and M&A chatter. Is this a sector to

Healthcare giant $UnitedHealth(UNH)$ obliterated and is on track for its biggest loss in 27 years.Keydata: EPS of $7.20 missing expectations of $7.29, Revenue of $109.6B missing expectations of $111.6B.Why is $UNH down 23%? An amazing buying opportunityQ1 2025 Earnings Report AnalysisCompany OverviewUnitedHealth Group is a globally leading diversified healthcare company, operating primarily through two business segments: UnitedHealthcare (which provides health insurance and benefits services) and Optum (which offers information and technology-supported health services). The company is committed to helping people live healthier lives through innovative healthcare solutions and efficient operating models.Business and Business Model IntroductionUnited

On Wed, 16 Apr 2025, US stock markets experienced another sharp decline, with all 3 major indices closing significantly lower. (see below) This marked a continuation of the week’s downward trend, erasing earlier gains and deepening investor anxiety. By the time market called it a day: DJIA : -1.73% (-699.57 to 39,669.39). S&P 500: -2.24% (-120.93 to 5,275.70). Nasdaq: -3.07% (-516.01 to 16,307.16). Root Causes. The market’s fall was driven by a combination of escalating trade tensions and disappointing corporate news: (1) Fed’s Chair Pessimism: President Donald Trump’s aggressive new tariffs on Chinese imports and the uncertainty surrounding future trade policy have rattled investors. Fed Chair Jerome Powell warned that these tariffs are unprecedented in scale and could result in (a) h

As per my Thursday post, US market did not rally and close on a high (click here ! for details, Repost to share !). The media said US stocks closed mixed on Thursday, booking weekly losses on the final session of the week. Most media “agreed” that the 2 factors that most affected market sentiments, particularly blue-chip Dow Jones Industrial Average were: Trump’s latest bitch-fit over what Fed chair Jerome Powell had said in his xx speech about overall US economy. Historic drop in $UnitedHealth(UNH)$ after the insurer reported its quarterly earnings and delivered an outlook that disappointed Wall Street.

$SPDR S&P Biotech ETF ( $Spdr S&P Biotech Etf(XBI)$ )$ $Pfizer ( $Pfizer(PFE)$ )$ $S&P 500(. $S&P 500(.SPX)$ )$ $Dow Jones Industrial Average(. $Dow Jones(.DJI)$ )$As of April 18, 2025, the U.S. stock market is reeling from a volatile week, with the S&P 500 shedding 2.8% on April 17 and the Dow Jones Industrial Average dropping 1,200 points in a single session. Fears of escalating trade tensions and a hawkish Federal Reserve have sparked widespread selling. Yet, amid the chaos, biotech stocks are staging an unexpected rally, driven by breakthrough drug approvals and M&A chatter. Is this a sector to